Search Results - "Espíndola, Milena S."

Refine Results
  1. 1

    CD18 Regulates Monocyte Hematopoiesis and Promotes Resistance to Experimental Schistosomiasis by Souza, Camila O S, Espíndola, Milena S, Fontanari, Caroline, Prado, Morgana K B, Frantz, Fabiani G, Rodrigues, Vanderlei, Gardinassi, Luiz G, Faccioli, Lúcia H

    Published in Frontiers in immunology (31-08-2018)
    “…Infection with causes a chronic parasitic disease that progress to severe liver and gastrointestinal damage, and eventually death. During its development into…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients by Espíndola, Milena S, Lima, Leonardo J G, Soares, Luana S, Cacemiro, Maira C, Zambuzi, Fabiana A, de Souza Gomes, Matheus, Amaral, Laurence R, Bollela, Valdes R, Martins-Filho, Olindo A, Frantz, Fabiani G

    Published in PloS one (18-12-2015)
    “…Successful highly active antiretroviral therapy (HAART) has changed the outcome of AIDS patients worldwide because the complete suppression of viremia improves…”
    Get full text
    Journal Article
  4. 4

    Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis by Espindola, Milena S, Habiel, David M, Narayanan, Rohan, Jones, Isabelle, Coelho, Ana L, Murray, Lynne A, Jiang, Dianhua, Noble, Paul W, Hogaboam, Cory M

    “…Idiopathic pulmonary fibrosis (IPF) is characterized by aberrant lung remodeling, which progressively abolishes lung function in an RTK (receptor tyrosine…”
    Get full text
    Journal Article
  5. 5

    HIV infection: focus on the innate immune cells by Espíndola, Milena S., Soares, Luana S., Galvão-Lima, Leonardo J., Zambuzi, Fabiana A., Cacemiro, Maira C., Brauer, Verônica S., Frantz, Fabiani G.

    Published in Immunologic Research (01-12-2016)
    “…Innate immune cells play a critical role during the onset of HIV infection and remain active until the final events that characterize AIDS. The viral impact on…”
    Get full text
    Journal Article Book Review
  6. 6
  7. 7

    Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis by Zambuzi, Fabiana A., Cardoso-Silva, Priscilla M., Espindola, Milena S., Soares, Luana S., Galvão-Lima, Leonardo J., Brauer, Verônica S., Gomes, Matheus S., Amaral, Laurence R., Schaller, Matthew, Bollela, Valdes R., Frantz, Fabiani G.

    Published in Cytokine (Philadelphia, Pa.) (01-12-2016)
    “…[Display omitted] •Active tuberculosis patients have increased plasma levels of IL-6, IP-10, TNF-α, sCD163 and sCD14.•Simultaneous detection of plasma sCD14…”
    Get full text
    Journal Article
  8. 8

    DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis by Habiel, David M, Hohmann, Miriam S, Espindola, Milena S, Coelho, Ana Lucia, Jones, Isabelle, Jones, Heather, Carnibella, Richard, Pinar, Isaac, Werdiger, Freda, Hogaboam, Cory M

    Published in BMC pulmonary medicine (29-08-2019)
    “…Recent studies have highlighted the contribution of senescent mesenchymal and epithelial cells in Idiopathic Pulmonary Fibrosis (IPF), but little is known…”
    Get full text
    Journal Article
  9. 9

    Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection by Galvão-Lima, Leonardo J., Espíndola, Milena S., Soares, Luana S., Zambuzi, Fabiana A., Cacemiro, Maira, Fontanari, Caroline, Bollela, Valdes R., Frantz, Fabiani G.

    “…Three decades after HIV recognition and its association with AIDS development, many advances have emerged – especially related to prevention and treatment…”
    Get full text
    Journal Article
  10. 10

    Mycobacterium tuberculosis expressing phospholipase C subverts PGE2 synthesis and induces necrosis in alveolar macrophages by Assis, Patricia A, Espíndola, Milena S, Paula-Silva, Francisco W G, Rios, Wendy M, Pereira, Priscilla A T, Leão, Sylvia C, Silva, Célio L, Faccioli, Lúcia H

    Published in BMC microbiology (19-05-2014)
    “…Phospholipases C (PLCs) are virulence factors found in several bacteria. In Mycobacterium tuberculosis (Mtb) they exhibit cytotoxic effects on macrophages, but…”
    Get full text
    Journal Article
  11. 11

    CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling by Habiel, David M, Espindola, Milena S, Jones, Isabelle C, Coelho, Ana Lucia, Stripp, Barry, Hogaboam, Cory M

    Published in JCI insight (23-08-2018)
    “…Idiopathic pulmonary fibrosis (IPF) is a devastating fibrotic lung disease of unknown etiology and limited therapeutic options. In this report, we characterize…”
    Get full text
    Journal Article
  12. 12

    Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis by Huang, Yong, Guzy, Rob, Ma, Shwu-Fan, Bonham, Catherine A, Jou, Jonathan, Schulte, Jefree J, Kim, John S, Barros, Andrew J, Espindola, Milena S, Husain, Aliya N, Hogaboam, Cory M, Sperling, Anne I, Noth, Imre

    Published in BMJ open respiratory research (01-02-2023)
    “…RationaleContribution of central lung tissues to pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unknown.ObjectiveTo ascertain the relationship…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis by Espindola, Milena S, Habiel, David M, Coelho, Ana Lucia, Stripp, Barry, Parks, William C, Oldham, Justin, Martinez, Fernando J, Noth, Imre, Lopez, David, Mikels-Vigdal, Amanda, Smith, Victoria, Hogaboam, Cory M

    “…Aberrant lung remodeling in idiopathic pulmonary fibrosis (IPF) is characterized by elevated MMP9 (matrix metalloproteinase 9) expression, but the precise role…”
    Get full text
    Journal Article
  17. 17

    Immune mechanisms in fibrotic interstitial lung disease by Kamiya, Mari, Carter, Hannah, Espindola, Milena S, Doyle, Tracy J, Lee, Joyce S, Merriam, Louis T, Zhang, Fan, Kawano-Dourado, Leticia, Sparks, Jeffrey A, Hogaboam, Cory M, Moore, Bethany B, Oldham, William M, Kim, Edy Y

    Published in Cell (11-07-2024)
    “…Fibrotic interstitial lung diseases (fILDs) have poor survival rates and lack effective therapies. Despite evidence for immune mechanisms in lung fibrosis,…”
    Get more information
    Journal Article
  18. 18

    Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice by Habiel, David M., Espindola, Milena S., Coelho, Ana L., Hogaboam, Cory M.

    Published in The American journal of pathology (01-04-2018)
    “…Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown etiopathogenesis with limited therapeutic options. IPF is characterized by an…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis by Jones, Isabelle C., Espindola, Milena S., Narayanan, Rohan, Coelho, Ana L., Habiel, David M., Boehme, Stefen A., Ly, Tai Wei, Bacon, Kevin B., Hogaboam, Cory M.

    Published in Scientific reports (24-12-2019)
    “…Idiopathic Pulmonary Fibrosis (IPF) is a disease with a devastating prognosis characterized by unrelenting lung scarring. Aberrant activation of lung…”
    Get full text
    Journal Article